Synergy between baicalein and penicillins against penicillinase-producing Staphylococcus aureus

International Journal of Medical Microbiology

Volumn 305, Issue 6, 2015, Pages 501-504

  Qian, Minyi ^a   Tang, Shusheng ^a   Wu, Congming ^a   Wang, Yang ^a   He, Tao ^a   Chen, Tingting ^a   Xiao, Xilong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Baicalein; MRSA; Penicillinase; Penicillinase producing Staphylococcus aureus; Penicillins; Synergism

Indexed keywords

AMOXICILLIN; BAICALEIN; CLAVULANIC ACID; PENICILLIN G; PENICILLINASE; ANTIINFECTIVE AGENT; ENZYME INHIBITOR; FLAVANONE DERIVATIVE; PENICILLIN DERIVATIVE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BOVINE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; FRACTIONAL INHIBITORY CONCENTRATION; IN VITRO STUDY; INHIBITORY CONCENTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLINASE PRODUCING STAPHYLOCOCCUS AUREUS; PIG; STAPHYLOCOCCUS AUREUS; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; PENICILLIN RESISTANCE;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG SYNERGISM; ENZYME INHIBITORS; FLAVANONES; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PENICILLINASE; PENICILLINS; STAPHYLOCOCCUS AUREUS;

EID: 84940452269     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2015.05.001     Document Type: Article

References (34)

1. Argudin M.A., Mendoza M.C., Martin M.C., Rodicio M.R. Molecular basis of antimicrobial drug resistance in Staphylococcus aureus isolates recovered from young healthy carriers in Spain. Microb. Pathog. 2014, 74:8-14.
2. Blazquez J., Baquero M.R., Canton R., Alos I., Baquero F. Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 1993, 37:2059-2063.
3. Chaibi E.B., Sirot D., Paul G., Labia R. Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother. 1999, 43:447-458.
4. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg. Infect. Dis. 2001, 7:178-182.
5. Chan B.C.L., Ip M., Lau C.B.S., Lui S.L., Jolivalt C., Ganem-Elbaz C., Litaudon M., Reiner N.E., Gong H., See R.H., Fung K.P., Leung P.C. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase. J. Ethnopharmacol. 2011, 137:767-773.
6. Chen J., Li Z., Chen A.Y., Ye X., Luo H., Rankin G.O., Chen Y.C. Inhibitory effect of baicalin and baicalein on ovarian cancer cells. Int. J. Mol. Sci. 2013, 14:6012-6025.
7. Commission of Chinese Pharmacopoeia Penicillinase and enzyme assay. Appendix of Chinese Pharmacopoeia Commission (2000 ed.), Beijing 1999, 84-85.
8. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. Approved Standard VET01-A4 2013, CLSI, Wayne, PA, USA. 4th ed.
9. Coulton S., Francois I. Beta-lactamases: targets for drug design. Prog. Med. Chem. 1994, 31:297-349.
10. Eumkeb G., Sakdarat S., Siriwong S. Reversing beta-lactam antibiotic resistance of Staphylococcus aureus with galangin from alpinia officinarum hance and synergism with ceftazidime. Phytomedicine 2010, 18:40-45.
11. Franciolli M., Bille J., Glauser M.P., Moreillon P. Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 1991, 163:514-523.
12. Fujita M., Shiota S., Kuroda T., Hatano T., Yoshida T., Mizushima T., Tsuchiya T. Remarktable synergies between baicalein and tetracycline, and baicalein and beta-lactams against methicillin-resistant Staphylococcus aureus. Microbiol. Immunol. 2005, 49:391-396.
13. Huang H.C., Wang H.R., Hsieh L.M. Antiproliferative effect of baicalein, a flavonoid from a Chinese herb, on vascular smooth muscle cell. Eur. J. Pharmacol. 1994, 251:91-93.
14. Ikemoto S., Sugimura K., Yoshida N., Yasumoto R., Wada S., Yamamoto K., Kishimoto T. Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 2000, 55:951-955.
15. Kohner P., Uhl J., Kolbert C., Persing D., Cockerill F. Comparison of susceptibility testing methods with mecA gene analysis for determining oxacillin (methicillin) resistance in clinical isolates of Staphylococcus aureus and coagulase-negative Staphylococcus spp. J. Clin. Microbiol. 1999, 37:2952-2961.
16. Li L., Liu W.-Y., Feng F., Wu C.-Y., Xie N. Synthesis and in vitro cytotoxicity evaluation of baicalein amino acid derivatives. Chin. J. Nat. Med. 2013, 11:284-288.
17. Li M., Shi A., Pang H., Xue W., Li Y., Cao G., Yan B., Dong F., Li K., Xiao W., He G., Du G., Hu X. Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects. J. Ethnopharmacol. 2014, 156:210-215.
18. Liu I.X., Durham D.G., Richards R.M.E. Baicalin synergy with beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus and other beta-lactam-resistant strains of S. aureus. J. Pharm. Pharmacol. 2000, 52:361-366.
19. Lowy F.D. Staphylococcus aureus infections - reply. N. Engl. J. Med. 1998, 339:2026-2027.
20. Lowy F.D. Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Invest. 2003, 111:1265-1273.
21. Maddux M.S. Effects of beta-lactamase-mediated antimicrobial resistance: the role of beta-lactamase inhibitors. Pharmacotherapy 1991, 11:S40-S50.
22. Martineau F., Picard F.J., Grenier L., Roy P.H., Ouellette M., Bergeron M.G., Trial E. Multiplex PCR assays for the detection of clinically relevant antibiotic resistance genes in staphylococci isolated from patients infected after cardiac surgery. J. Antimicrob. Chemother. 2000, 46:527-533.
23. Norden C.W., Wentzel H., Keleti E. Comparison of techniques for measurement of in vitro antibiotic synergism. J. Infect. Dis. 1979, 140:629-633.
24. Odds F.C. Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 2003, 52:1.
25. Okita K., Li Q., Murakamio T., Takahashi M. Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. Eur. J. Cancer Prev. 1993, 2:169-175.
26. Padmanabhan R.A., Fraser T.G. The emergence of methicillm-resistant Staphylococcus aureus in the community. Cleve. Clin. J. Med. 2005, 72:235-241.
27. Peton V., Le Loir Y. Staphylococcus aureus in veterinary medicine. Infect. Genet. Evol. 2014, 21:602-615.
28. Stapleton P., Wu P.J., King A., Shannon K., French G., Phillips I. Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob. Agents Chemother. 1995, 39:2778-2783.
29. Tzouvelekis L.S., Zissis N.P., Gazouli M., Tzelepi E., Legakis N.J. In vitro comparative assessment of beta-lactamase inhibitors and their penicillin combinations against selected enterobacteria. Int. J. Antimicrob. Agents 1997, 8:193-197.
30. Wagner H., Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine 2009, 16:97-110.
31. Wang D., Wang Z., Yan Z., Wu J., Ali T., Li J., Lv Y., Han B. Bovine mastitis Staphylococcus aureus: antibiotic susceptibility profile, resistance genes and molecular typing of methicillin-resistant and methicillin-sensitive strains in China. Infect. Genet. Evol. 2015, 31C:9-16.
32. Zhao W.H., Asano N., Hu Z.Q., Shimamura T. Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase. J. Pharm. Pharmacol. 2003, 55:735-740.
33. Zhao W.H., Hu Z.Q., Hara Y., Shimamura T. Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus. Antimicrob. Agents Chemother. 2002, 46:2266-2268.
34. Zhou Q., Wei X., Dou W., Chou G., Wang Z. Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins. Carbohydr. Polym. 2013, 95:733-739.